These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21679836)

  • 21. Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma.
    Massarelli E; Lin H; Ginsberg LE; Tran HT; Lee JJ; Canales JR; Williams MD; Blumenschein GR; Lu C; Heymach JV; Kies MS; Papadimitrakopoulou V
    Ann Oncol; 2015 Jul; 26(7):1476-80. PubMed ID: 26025965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axillary skin malignancy: a rare breast cancer presentation.
    Miranda BH; Malahias M; El-Said TF; Fahmy FS
    Ann Plast Surg; 2014 May; 72(5):513-4. PubMed ID: 23241794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma.
    Gurney B; Newlands C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):294-300. PubMed ID: 24559975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of indolent primary cutaneous B-cell lymphomas with subcutaneous interferon-alfa.
    Vandersee S; Terhorst D; Humme D; Beyer M
    J Am Acad Dermatol; 2014 Apr; 70(4):709-715. PubMed ID: 24433874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of erlotinib as adjuvant chemoprevention in high-risk head and neck cancer patients.
    Rosenthal EL; Chung TK; Carroll WR; Clemons L; Desmond R; Nabell L
    Ann Surg Oncol; 2014 Dec; 21(13):4263-9. PubMed ID: 25001094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining patients with high-risk cutaneous squamous cell carcinoma.
    Veness MJ
    Australas J Dermatol; 2006 Feb; 47(1):28-33. PubMed ID: 16405479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic basal cell carcinoma from a small tumor with lymphatic invasion.
    Grekin SJ; Bichakjian CK; Sabel MS; Chepeha DB; Fullen DR
    J Am Acad Dermatol; 2011 Jul; 65(1):e16-7. PubMed ID: 21679798
    [No Abstract]   [Full Text] [Related]  

  • 29. Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck.
    Khurana VG; Mentis DH; O'Brien CJ; Hurst TL; Stevens GN; Packham NA
    Am J Surg; 1995 Nov; 170(5):446-50. PubMed ID: 7485729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-excision of incompletely excised cutaneous squamous cell carcinoma: histological findings influence prognosis.
    Bovill ES; Banwell PE
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1390-5. PubMed ID: 22652292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome.
    Wang JT; Palme CE; Wang AY; Morgan GJ; Gebski V; Veness MJ
    J Laryngol Otol; 2013 Jan; 127 Suppl 1():S2-7. PubMed ID: 23046820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous granulomatous eruption and successful response to potent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanoma.
    Park JJ; Hawryluk EB; Tahan SR; Flaherty K; Kim CC
    JAMA Dermatol; 2014 Mar; 150(3):307-11. PubMed ID: 24352115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphatic mapping and sentinel lymphonodectomy in recurrent cutaneous squamous cell carcinomas.
    Cecchi R; Buralli L; de Gaudio C
    Eur J Dermatol; 2005; 15(6):478-9. PubMed ID: 16280303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cutaneous adenoid cystic carcinoma with lung and lymph node metastases.
    Doganay L; Bilgi S; Aygit C; Altaner S
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):383-5. PubMed ID: 15096169
    [No Abstract]   [Full Text] [Related]  

  • 36. Implantation metastasis of a hypopharyngeal carcinoma at the site of a percutaneous endoscopic gastrostomy.
    Kurdow R; Schniewind B; Delere Y; Boehle AS; Lüttges J; Doniec JM
    Endoscopy; 2003 May; 35(5):462. PubMed ID: 12701026
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathologic occult neck disease in patients with metastatic cutaneous squamous cell carcinoma to the parotid.
    Kirke DN; Porceddu S; Wallwork BD; Panizza B; Coman WB
    Otolaryngol Head Neck Surg; 2011 Apr; 144(4):549-51. PubMed ID: 21493233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma.
    Chua DT; Wei WI; Wong MP; Sham JS; Nicholls J; Au GK
    Head Neck; 2008 Jul; 30(7):863-7. PubMed ID: 18213730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21.
    Lim SH; Lee JY; Sun JM; Ahn JS; Park K; Ahn MJ
    J Thorac Oncol; 2014 Apr; 9(4):506-11. PubMed ID: 24736073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes.
    Goh A; Howle J; Hughes M; Veness MJ
    Australas J Dermatol; 2010 May; 51(2):113-7. PubMed ID: 20546217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.